Pregnancy and antibodies to phospholipids.

Por Walport, M J
Publicado em 1989

Respiration and connective tissue diseases.

Por Walport, M J
Publicado em 1987

Methods in Complement for Clinical Immunologists

Por Walport, M. J.
Publicado em 1986

Antiphospholipid antibodies and cardiovascular disease.

Por Beynon, H L, Walport, M J
Publicado em 1992

Giant cell arteritis.

Por Mason, J. C., Walport, M. J.
Publicado em 1992

The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.

Por Moldenhauer, F, Botto, M, Walport, M J
Publicado em 1988

Effects of C4 null alleles and homoduplications on quantitative expression of C4A and C4B.

Por Hammond, A, Ollier, W, Walport, M J
Publicado em 1992

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder.

Por Mackworth-Young, C G, Loizou, S, Walport, M J
Publicado em 1989

Sulphasalazine and regression of rheumatoid nodules.

Por Englert, H J, Hughes, G R, Walport, M J
Publicado em 1987

Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.

Por Ng, Y C, Schifferli, J A, Walport, M J
Publicado em 1988

Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders.

Por Loizou, S, Cofiner, C, Weetman, A P, Walport, M J
Publicado em 1992

Long-term management after splenectomy. Consider prophylaxis in systematic lupus erythematosus.

Por Davies, K. A., Beynon, H. L., Walport, M. J.
Publicado em 1994

Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide

Por Walport, M J, Hubbard, W N, Hughes, G R V
Publicado em 1982

Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis.

Por Loizou, S, Mackworth-Young, C G, Cofiner, C, Walport, M J
Publicado em 1990

Expression of MHC class I determinants on erythrocytes of SLE patients.

Por Giles, C M, Walport, M J, David, J, Darke, C
Publicado em 1987

Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma.

Por Lee, T H, Nagy, L, Nagakura, T, Walport, M J, Kay, A B
Publicado em 1982

Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.

Por Davies, K A, Peters, A M, Beynon, H L, Walport, M J
Publicado em 1992

The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.

Por Schifferli, J A, Ng, Y C, Paccaud, J P, Walport, M J
Publicado em 1989

A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).

Por Ng, Y C, Peters, D K, Cederholm-Williams, S A, Walport, M J
Publicado em 1987

Reduction in T gamma delta cell numbers and alteration in subset distribution in systemic lupus erythematosus.

Por Lunardi, C, Marguerie, C, Bowness, P, Walport, M J, So, A K
Publicado em 1991